Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 4 29-4, 2003, Pages

  Vazquez de Lara, Luis G ^a   Umstead, Todd M ^a   Davis, Sara E ^a   Phelps, David S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Gelatinase; Macrophage

Indexed keywords

COLECALCIFEROL; GELATINASE B; MESSENGER RNA; NEUTRALIZING ANTIBODY; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR 2;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ELASTOLYSIS; EMPHYSEMA; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SUPERNATANT;

EID: 0141568029     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00082.2003     Document Type: Article

References (53)

1. Atkinson JJ and Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28: 12-24, 2003.
2. Baritussio A, Alberti A, Quaglino D, Pettenazzo A, Dalzoppo D, Sartori L, and Pasquali-Ronchetti I. SP-A, SP-B, and SP-C in surfactant subtypes around birth: reexamination of alveolar life cycle of surfactant. Am J Physiol Lung Cell Mol Physiol 266: L436-L447, 1994.
3. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, and Shepherd VL. Purification of a cell-surface receptor for surfactant protein A. J Biol Chem 271: 16375-16383, 1996.
4. 1-proteinase inhibitor. Am J Physiol Lung Cell Mol Physiol 266: L593-L611, 1994.
5. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, and Tucker GC. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402: 111-115, 1997.
6. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, Fitzgerald MX, and O'Connor CM. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156: 240-247, 1997.
7. Finlay GA, Russell KJ, McMahon KJ, D'Arcy EM, Masterson JB, Fitzgerald MX, and O'Connor CM. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52: 502-506, 1997.
8. Frerking I, Gunther A, Seeger W, and Pison U. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 27: 1699-1717, 2001.
9. Gadek JE and Pacht ER. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 168, Suppl: 552-564, 1990.
10. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, and Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850, 1999.
11. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 13: 1455-1476, 1999.
12. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, and Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 168: 5989-5992, 2002.
13. Haagsman HP, Hawgood S, Sargeant T, Buckley D, White RT, Drickamer K, and Benson BJ. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem 262: 13877-13880, 1987.
14. Haddad IY, Zhu S, Ischiropoulos H, and Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol Lung Cell Mol Physiol 270: L281-L288, 1996.
15. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, Nagase H, French DL, and Quigley JP. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann NY Acad Sci 878: 372-387, 1999.
16. Hawkes SP, Li H, and Taniguchi GT. Zymography and reverse zymography for detecting MMPs and TIMPs. Methods Mol Biol 151: 399-410, 2001.
17. He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 106: 185-191, 1996.
18. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 42: 241-249, 1987.
19. Honda Y, Takahashi H, Kuroki Y, Akino T, and Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 109: 1006-1009, 1996.
20. Huang W, Wang G, Phelps DS, Al Mondhiry H, and Floros J. Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect. Am J Physiol Lung Cell Mol Physiol 283: L94-L102, 2002.
21. Hughes DA and Haslam PL. Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur Respir J 3: 1128-1139, 1990.
22. Kida K, Oda H, Yamano Y, and Kagawa J. Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J 10: 2124-2126, 1997.
23. Kleiner DE and Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329, 1994.
24. Koptides M, Umstead TM, Floros J, and Phelps DS. Surfactant protein A activates NF-κB in the THP-1 monocytic cell line. Am J Physiol Lung Cell Mol Physiol 273: L382-L388, 1997.
25. Kremlev SG and Phelps DS. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol Lung Cell Mol Physiol 267: L712-L719, 1994.
26. Krombach F, Gerlach JT, Padovan C, Burges A, Behr J, Beinert T, and Vogelmeier C. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J 9: 984-991, 1996.
27. Lemjabbar H, Gosset P, Lachapt-Zalcman E, Franco-Montoya ML, Wallaert B, Harf A, and Lafuma C. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 20: 903-913, 1999.
28. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, and Chung KF. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med 162: 1355-1360, 2000.
29. Mancini NM, Bene MC, Gerard H, Chabot F, Faure G, Polu JM, and Lesur O. Early effects of short-time cigarette smoking on the human lung - a study of bronchoalveolar lavage fluids. Lung 171: 277-291, 1993.
30. Mecham RP, Broekelmann TJ, Fliszar CJ, Shapiro SD, Welgus HG, and Senior RM. Elastin degradation by matrix metalloproteinases: cleavage site specificity and mechanisms of elastolysis. J Biol Chem 272: 18071-18076, 1997.
31. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, Voelker DR, Akino T, and Kuroki Y. Surfactant protein A inhibits peptidoglycan- induced tumor necrosis factor-α secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J Biol Chem 277: 6830-6837, 2002.
32. Ofulue AF and Ko M. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 277: L97-L105, 1999.
33. Opdenakker G, Van den Steen PE, and van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 22: 571-579, 2001.
34. Oulton NM, Janigan DT, MacDonald JMR, Faulkner GT, and Scott JE. Effects of smoke inhalation on alveolar surfactant subtypes in mice. Am J Pathol 145: 941-950, 1994.
35. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol 20: 269-292, 2001.
36. Phelps DS and Rose RM. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am Rev Respir Dis 143: 1072-1075, 1991.
37. Prikk K, Maisi P, Sepper R, Stenman UH, Salo T, and Sorsa T. Association of trypsin-2 with activation of gelatinase B and collagenase-2 in human bronchoalveolar lavage fluid in vivo. Ann Med 33: 437-444, 2001.
38. Putman E, Van Golde LMG, and Haagsman HP. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 175: 75-103, 1997.
39. Rosseau S, Hammerl P, Maus U, Walmrath HD, Schutte H, Grimminger F, Seeger W, and Lohmeyer J. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 279: L25-L35, 2000.
40. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, and Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117: 684-694, 2000.
41. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, and Welgus HG. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266: 7870-7875, 1991.
42. Shapiro SD and Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 20: 1100-1102, 1999.
43. Shepherd VL and Lopez JP. The role of surfactant-associated protein A in pulmonary host defense. Immunol Res 23: 111-120, 2001.
44. Song M and Phelps DS. Comparison of SP-A and LPS effects on the THP-1 monocytic cell line. Am J Physiol Lung Cell Mol Physiol 279: L110-L117, 2000.
45. Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkila P, Tschesche H, Leinonen J, Osman S, and Stenman UH. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 272: 21067-21074, 1997.
46. Sternlicht MD and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
47. Suwabe A, Mason RJ, and Voelker DR. Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch Biochem Biophys 327: 285-291, 1996.
48. Tetley T. Matrix metalloproteinases: a role in emphysema? Thorax 52: 495-497, 1997.
49. Uthaisangsook S, Day NK, Bahna SL, Good RA, and Haraguchi S. Innate immunity and its role against infections. Ann Allergy Asthma Immunol 88: 253-264, 2002.
50. Wang G, Umstead TM, Phelps DS, Al Mondhiry H, and Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002.
51. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 77: 931-962, 1997.
52. Wright JR, Borron P, Brinker KG, and Folz RJ. Surfactant protein A: regulation of innate and adaptive immune responses in lung inflammation. Am J Respir Cell Mol Biol 24: 513-517, 2001.
53. Yao LJ, Fraher LJ, Veldhuizen RAW, Samuelson S, Borron P, Malloy J, Mccaig L, and Lewis JF. Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochim Biophys Acta 1535: 266-274, 2001.